There is a new vaccination plan against Covid-19 (but it is not yet available to everyone)

The new vaccination plan, not yet officially published, would foresee that phase 1 and phase 3 proceed in parallel with different categories of people to be vaccinated. Here are the details

(photo: Hakan Nural / Unsplash) With the approval and arrival of the anti-Covid vaccine developed by AstraZeneca and the University of Oxford, a new version of the vaccination plan also arrives, which completely changes the one released just two months ago. The Italian Medicines Agency (Aifa), in fact, has provided an indication that the AstraZeneca vaccine will be used for specific categories, all of which are not older than 55, thus making a new update necessary. Phase 1 and phase 3, as established in the recent summit between the government, the regions and the extraordinary commissioner for the emergency, will progress in parallel. But what does the latest update of the vaccination campaign provide in detail? Unfortunately, although days have passed, the official vaccination plan has not yet been made public, except to the regions and some newspapers. On the dedicated website, in fact, the latest update was last January 20.

To describe it, for example, is the Health newspaper, which even publishes screenshots of the plan. The vaccination campaign, it is reported, would consist of four phases: phase 1, which includes health and social health workers, the over 80s and the RSA; phase 2, with the over 60s, people with frailty of all ages, socio-demographic groups at higher risk of serious illness or death, high priority school staff. And again: in phase 3 there would be teaching and non-teaching school and university staff, armed and police forces, prisons, community places and those working in other essential services, people with moderate comorbidity of all ages. And finally, phase 4, i.e. the remaining population. While phase 1 and 2 aim to decrease the lethality of Covid-19, phases 3 and 4 aim to limit the spread of the coronavirus.

In the new version of the vaccination plan, moreover, it would be explicit for the first time the type of vaccine and quantified how many people will be administered, always based on the 4 phases. The Pfizer or Moderna vaccine will be administered in phase 1 and phase 2, respectively consisting of approximately 6 and a half million and nearly 20 million people, while phase 3, with just under 4 million individuals, will be given to AstraZeneca, while Phase 4, consisting of over 20 million people, will be given a vaccine "according to availability".

But how many doses of the vaccine are coming? According to the new supply plan (to which, however, the doses of Pfizer purchased by the EU in early January have not yet been added), this month should arrive 1.25 million doses of AstraZeneca, 2.27 million Pfizer and 520 thousand of Moderna. Next month, however, 4 million doses of AstraZeneca, 3.5 million Pfizer and 690 thousand of Moderna are expected to arrive. A total of doses, if calculated from December, of about 13 million.